Full Library
Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
Resource type
Journal Article
Authors/contributors
- Kampouri, Eleftheria (Author)
- Zamora, Danniel (Author)
- Kiem, Erika S. (Author)
- Liu, Winnie (Author)
- Ibrahimi, Sarah (Author)
- Blazevic, Rachel L. (Author)
- Lovas, Erika A. (Author)
- Kimball, Louise E. (Author)
- Huang, Meei-Li (Author)
- Jerome, Keith R. (Author)
- Ueda Oshima, Masumi (Author)
- Mielcarek, Marco (Author)
- Zerr, Danielle M. (Author)
- Boeckh, Michael J. (Author)
- Krantz, Elizabeth M. (Author)
- Hill, Joshua A. (Author)
Title
Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis
Publication
Clinical Microbiology and Infection
Date
11/2023
Volume
29
Issue
11
Pages
1450.e1-1450.e7
Journal Abbr
Clinical Microbiology and Infection
Accessed
11/2/23, 9:50 AM
ISSN
1198743X
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Kampouri, E., Zamora, D., Kiem, E. S., Liu, W., Ibrahimi, S., Blazevic, R. L., Lovas, E. A., Kimball, L. E., Huang, M.-L., Jerome, K. R., Ueda Oshima, M., Mielcarek, M., Zerr, D. M., Boeckh, M. J., Krantz, E. M., & Hill, J. A. (2023). Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis. Clinical Microbiology and Infection, 29(11), 1450.e1-1450.e7. https://doi.org/10.1016/j.cmi.2023.07.026
HEME-ONC AND CELLULAR THERAPIES
Link to this record